By Gina Shaw and Marie Rosenthal
The Department of Health and Human Services (HHS) announced the first 10 drugs covered under Medicare Part D selected for negotiation under the Inflation Reduction Act (IRA), which was signed into law in August 2022.
The list is heavy on drugs for diabetes, heart failure and kidney disease, and also includes drugs for blood clot and stroke prevention, blood cancers, and inflammatory conditions such as rheumatoid arthritis and psoriasis.
This is a historic